Mary M. Rozenman, See Remarks at Aimmune Therapeutics, Inc. (AIMT), sold 48,192 shares at $17.60 ($848K) on 2016-11-04, disclosed to the SEC on 2016-11-04.
Open-market sale of $848k AIMT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.60 | 24,096 | $424K | 50.0% |
| 2 | $17.60 | 24,096 | $424K | 50.0% |
| Total | $17.60 avg | 48,192 | $848K | 100% |
| Filing → |
| AIMT | SELL | 2018-01-04 | $489K | — | Filing → |
| AIMT | SELL | 2017-12-28 | $381K | — | Filing → |
| AIMT | SELL | 2017-09-11 | $675K | — | Filing → |